Press-release for stocks for dbv technologies s.a.

DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
Published: 2023-02-27 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -48.9% | O: 6.62% H: 0.69% C: -3.45%
report year financial results

DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
Published: 2022-12-23 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -41.1% | O: 31.36% H: 0.0% C: -7.1%
fda lifted clinical hold

DBV Technologies Announces Private Placement Financing of $194 Million
Published: 2022-06-09 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -62.02% | O: 6.01% H: 76.8% C: 67.53%

DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference
Published: 2022-01-07 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -57.62% | O: 4.27% H: 0.0% C: 0.0%
conference

DBV Technologies to Participate in an Upcoming Investor Conference
Published: 2021-11-24 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -76.2% | O: 0.17% H: 0.0% C: 0.0%
conference

DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021
Published: 2021-11-01 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -77.06% | O: 11.88% H: 0.0% C: -4.13%
trial

DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021
Published: 2021-03-01 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -87.01% | O: 0.93% H: 3.15% C: 1.11%
financial results results

DBV Technologies to Participate in Upcoming AAAAI 2021 Congress
Published: 2021-02-24 (Crawled : 07:00) - globenewswire.com
DBVT | $0.714 2.73% 2.66% 22K

| -87.22% | O: 1.65% H: 0.72% C: 0.54%
technology